For the sake of stoking hope, I wish to discuss the recent advance in surgical technology called MarginProbe.
Stanford’s biodesign program is 15 years old.
We need statistics to make society and medicine safer and more effective. We need baseline values so that we know when there are problems. Yet ultimately we cannot control every number we measure, and maybe we shouldn’t try. Averages may be calculated from individuals, but individuals can’t be calculated from the average.
The absolute best option for the FDA in the case of 23andMe is to consider medical processes using medical devices as inherent enough in those devices to warrant their regulatory oversight.
New wireless technology developed by Stanford researchers could eliminate the need for batteries in implantable medical devices.
Embrace, a Stanford-grown San Francisco social enterprise, has developed a baby warmer designed to keep newborns warm during the first few days of life.